Thomas Flaten

Stock Analyst at Lake Street

(0)
# 3555
Out of 5,298 analysts
43
Total ratings
34.48%
Success rate
-4.29%
Average return
16 Stocks
Name Action Price Target Current % Upside Ratings Updated
OCX OncoCyte
Initiates Coverage On: Buy
5
2.74 82.48% 5 Mar 28, 2025
OPTN OptiNose
Downgrades: Hold
17 9
9.08 -0.88% 5 Mar 20, 2025
CKPT Checkpoint Therapeut...
Downgrades: Hold
7 5
4.01 2.24% 5 Mar 10, 2025
AQST Aquestive Therapeuti...
Maintains: Buy
10 8
2.71 195.2% 2 Mar 7, 2025
EVAX Evaxion Biotech
Maintains: Buy
35 6
1.55 287.1% 2 Feb 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 9
3.12 188.46% 2 Jan 8, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
34 40
18.58 115.29% 5 Nov 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
9
7.21 24.83% 1 Sep 6, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
1
n/a n/a 1 Apr 19, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
4 3
0.63 376.19% 3 Mar 12, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
19 11
2.17 406.91% 3 Mar 5, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
5 3
n/a n/a 2 Aug 10, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
34 25
20.86 19.85% 2 Aug 9, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14400 1440
2.3 62508.7% 2 Nov 17, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
14 8
3.52 127.27% 1 Jul 7, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Hold
n/a
n/a n/a 2 May 13, 2022